FOSRx acquires F.A.S.T. to strengthens its specialty pharmacy offerings

F.A.S.T. will retain its brand but function under FOSRx.
F.A.S.T. will retain its brand but function under FOSRx. | Contributed image
Factor One Source Pharmacy (FOSRx), a specialty pharmacy that serves individuals with complex or hard-to-manage medications, will acquire Fast Access Specialty Therapeutics (F.A.S.T.), a quickly growing pharmacy that has made a name for itself through industry-leading customer satisfaction, patient engagement and strong financial performance.
"The F.A.S.T. team has grown a fantastic business centered on support and quality services for patients," FOSRx CEO Sajal Roy said. "Together we can accelerate the growth of the Factor One Source brand as we seek to empower every patient we serve to live fulfilled, healthy lives."
Under the new arrangement, F.A.S.T. will retain its brand but function under FOSRx. F.A.S.T. will add “Powered by Factor One Source Pharmacy” to its name, and Roy will become CEO to both companies.
"Today marks the beginning of an exciting new chapter for F.A.S.T., one which we believe will deliver significant value to our patients and partners," F.AS.T.'s CEO Adam Myers said. "We have deep respect for FOSRx and it's clear they share our commitment to delivering top-notch care and invaluable service. We are proud of the company our team has built and are confident that FOSRx will accelerate F.A.S.T.'s important mission given the strength of its national presence and resources."